Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Service & Software > Exosome Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Exosome Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published: 2024-01-11

Pages: 109 Pages

Report ld: 3030867

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.

The global market for Exosome Technologies was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Exosome Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Exosome Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Exosome Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Exosome Technologies include Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Evox Therapeutics, Exosome Diagnostics, Inc., ExonanoRNA LLC.,, Codiak BioSciences and Esperite Group, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Exosome Technologies, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Exosome Technologies by region & country, by Type, and by Application.

The Exosome Technologies market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Technologies.

Market Segmentation

Report Metric
Details
Report Title
Exosome Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Market Size Available for Years
2024-2030
Global Exosome Technologies Companies Covered
Aegle Therapeutics
Anjarium Biosciences
Aruna Biomedical
Carmine Therapeutics
Evox Therapeutics
Exosome Diagnostics, Inc.
ExonanoRNA LLC.,
Codiak BioSciences
Esperite Group
Tavec Pharmaceuticals
Global Exosome Technologies Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Exosome Technologies Market, Segment by Type
Transmission Electron Microscopy
Nanoparticle Tracking Analysis
Western Blot Molecular Marker Detection
Global Exosome Technologies Market, Segment by Application
Healthcare Providers
Pharmaceutical & Biotechnology Companies
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Exosome Technologies manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Exosome Technologies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Exosome Technologies in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Exosome Technologies Product Introduction
    1.2 Global Exosome Technologies Market Size Forecast
    1.3 Exosome Technologies Market Trends & Drivers
        1.3.1 Exosome Technologies Industry Trends
        1.3.2 Exosome Technologies Market Drivers & Opportunity
        1.3.3 Exosome Technologies Market Challenges
        1.3.4 Exosome Technologies Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Exosome Technologies Players Revenue Ranking (2023)
    2.2 Global Exosome Technologies Revenue by Company (2019-2024)
    2.3 Key Companies Exosome Technologies Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Exosome Technologies Product Offered
    2.5 Key Companies Time to Begin Mass Production of Exosome Technologies
    2.6 Exosome Technologies Market Competitive Analysis
        2.6.1 Exosome Technologies Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Exosome Technologies Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Technologies as of 2023)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Transmission Electron Microscopy
        3.1.2 Nanoparticle Tracking Analysis
        3.1.3 Western Blot Molecular Marker Detection
    3.2 Global Exosome Technologies Sales Value by Type
        3.2.1 Global Exosome Technologies Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Exosome Technologies Sales Value, by Type (2019-2030)
        3.2.3 Global Exosome Technologies Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Healthcare Providers
        4.1.2 Pharmaceutical & Biotechnology Companies
        4.1.3 Others
    4.2 Global Exosome Technologies Sales Value by Application
        4.2.1 Global Exosome Technologies Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Exosome Technologies Sales Value, by Application (2019-2030)
        4.2.3 Global Exosome Technologies Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region
    5.1 Global Exosome Technologies Sales Value by Region
        5.1.1 Global Exosome Technologies Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Exosome Technologies Sales Value by Region (2019-2024)
        5.1.3 Global Exosome Technologies Sales Value by Region (2025-2030)
        5.1.4 Global Exosome Technologies Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Exosome Technologies Sales Value, 2019-2030
        5.2.2 North America Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Exosome Technologies Sales Value, 2019-2030
        5.3.2 Europe Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Exosome Technologies Sales Value, 2019-2030
        5.4.2 Asia Pacific Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Exosome Technologies Sales Value, 2019-2030
        5.5.2 South America Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Exosome Technologies Sales Value, 2019-2030
        5.6.2 Middle East & Africa Exosome Technologies Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Exosome Technologies Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Exosome Technologies Sales Value
    6.3 United States
        6.3.1 United States Exosome Technologies Sales Value, 2019-2030
        6.3.2 United States Exosome Technologies Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Exosome Technologies Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Exosome Technologies Sales Value, 2019-2030
        6.4.2 Europe Exosome Technologies Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Exosome Technologies Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Exosome Technologies Sales Value, 2019-2030
        6.5.2 China Exosome Technologies Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Exosome Technologies Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Exosome Technologies Sales Value, 2019-2030
        6.6.2 Japan Exosome Technologies Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Exosome Technologies Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Exosome Technologies Sales Value, 2019-2030
        6.7.2 South Korea Exosome Technologies Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Exosome Technologies Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Exosome Technologies Sales Value, 2019-2030
        6.8.2 Southeast Asia Exosome Technologies Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Exosome Technologies Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Exosome Technologies Sales Value, 2019-2030
        6.9.2 India Exosome Technologies Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Exosome Technologies Sales Value by Application, 2023 VS 2030

7 Company Profiles
    7.1 Aegle Therapeutics
        7.1.1 Aegle Therapeutics Profile
        7.1.2 Aegle Therapeutics Main Business
        7.1.3 Aegle Therapeutics Exosome Technologies Products, Services and Solutions
        7.1.4 Aegle Therapeutics Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.1.5 Aegle Therapeutics Recent Developments
    7.2 Anjarium Biosciences
        7.2.1 Anjarium Biosciences Profile
        7.2.2 Anjarium Biosciences Main Business
        7.2.3 Anjarium Biosciences Exosome Technologies Products, Services and Solutions
        7.2.4 Anjarium Biosciences Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.2.5 Anjarium Biosciences Recent Developments
    7.3 Aruna Biomedical
        7.3.1 Aruna Biomedical Profile
        7.3.2 Aruna Biomedical Main Business
        7.3.3 Aruna Biomedical Exosome Technologies Products, Services and Solutions
        7.3.4 Aruna Biomedical Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.3.5 Carmine Therapeutics Recent Developments
    7.4 Carmine Therapeutics
        7.4.1 Carmine Therapeutics Profile
        7.4.2 Carmine Therapeutics Main Business
        7.4.3 Carmine Therapeutics Exosome Technologies Products, Services and Solutions
        7.4.4 Carmine Therapeutics Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.4.5 Carmine Therapeutics Recent Developments
    7.5 Evox Therapeutics
        7.5.1 Evox Therapeutics Profile
        7.5.2 Evox Therapeutics Main Business
        7.5.3 Evox Therapeutics Exosome Technologies Products, Services and Solutions
        7.5.4 Evox Therapeutics Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.5.5 Evox Therapeutics Recent Developments
    7.6 Exosome Diagnostics, Inc.
        7.6.1 Exosome Diagnostics, Inc. Profile
        7.6.2 Exosome Diagnostics, Inc. Main Business
        7.6.3 Exosome Diagnostics, Inc. Exosome Technologies Products, Services and Solutions
        7.6.4 Exosome Diagnostics, Inc. Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.6.5 Exosome Diagnostics, Inc. Recent Developments
    7.7 ExonanoRNA LLC.,
        7.7.1 ExonanoRNA LLC., Profile
        7.7.2 ExonanoRNA LLC., Main Business
        7.7.3 ExonanoRNA LLC., Exosome Technologies Products, Services and Solutions
        7.7.4 ExonanoRNA LLC., Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.7.5 ExonanoRNA LLC., Recent Developments
    7.8 Codiak BioSciences
        7.8.1 Codiak BioSciences Profile
        7.8.2 Codiak BioSciences Main Business
        7.8.3 Codiak BioSciences Exosome Technologies Products, Services and Solutions
        7.8.4 Codiak BioSciences Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.8.5 Codiak BioSciences Recent Developments
    7.9 Esperite Group
        7.9.1 Esperite Group Profile
        7.9.2 Esperite Group Main Business
        7.9.3 Esperite Group Exosome Technologies Products, Services and Solutions
        7.9.4 Esperite Group Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.9.5 Esperite Group Recent Developments
    7.10 Tavec Pharmaceuticals
        7.10.1 Tavec Pharmaceuticals Profile
        7.10.2 Tavec Pharmaceuticals Main Business
        7.10.3 Tavec Pharmaceuticals Exosome Technologies Products, Services and Solutions
        7.10.4 Tavec Pharmaceuticals Exosome Technologies Revenue (US$ Million) & (2019-2024)
        7.10.5 Tavec Pharmaceuticals Recent Developments

8 Industry Chain Analysis
    8.1 Exosome Technologies Industrial Chain
    8.2 Exosome Technologies Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Exosome Technologies Sales Model
        8.5.2 Sales Channel
        8.5.3 Exosome Technologies Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Exosome Technologies Market Trends
    Table 2. Exosome Technologies Market Drivers & Opportunity
    Table 3. Exosome Technologies Market Challenges
    Table 4. Exosome Technologies Market Restraints
    Table 5. Global Exosome Technologies Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Exosome Technologies Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Exosome Technologies Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Exosome Technologies Product Type
    Table 9. Key Companies Time to Begin Mass Production of Exosome Technologies
    Table 10. Global Exosome Technologies Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Technologies as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Exosome Technologies Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Exosome Technologies Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Exosome Technologies Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Exosome Technologies Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Exosome Technologies Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Exosome Technologies Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Exosome Technologies Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Exosome Technologies Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Exosome Technologies Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Exosome Technologies Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Exosome Technologies Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Exosome Technologies Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Exosome Technologies Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Exosome Technologies Sales Value by Region (2019-2024) & (%)
    Table 27. Global Exosome Technologies Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Exosome Technologies Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Exosome Technologies Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Exosome Technologies Sales Value, (2025-2030) & (US$ Million)
    Table 31. Aegle Therapeutics Basic Information List
    Table 32. Aegle Therapeutics Description and Business Overview
    Table 33. Aegle Therapeutics Exosome Technologies Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Exosome Technologies Business of Aegle Therapeutics (2019-2024)
    Table 35. Aegle Therapeutics Recent Developments
    Table 36. Anjarium Biosciences Basic Information List
    Table 37. Anjarium Biosciences Description and Business Overview
    Table 38. Anjarium Biosciences Exosome Technologies Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Exosome Technologies Business of Anjarium Biosciences (2019-2024)
    Table 40. Anjarium Biosciences Recent Developments
    Table 41. Aruna Biomedical Basic Information List
    Table 42. Aruna Biomedical Description and Business Overview
    Table 43. Aruna Biomedical Exosome Technologies Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Exosome Technologies Business of Aruna Biomedical (2019-2024)
    Table 45. Aruna Biomedical Recent Developments
    Table 46. Carmine Therapeutics Basic Information List
    Table 47. Carmine Therapeutics Description and Business Overview
    Table 48. Carmine Therapeutics Exosome Technologies Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Exosome Technologies Business of Carmine Therapeutics (2019-2024)
    Table 50. Carmine Therapeutics Recent Developments
    Table 51. Evox Therapeutics Basic Information List
    Table 52. Evox Therapeutics Description and Business Overview
    Table 53. Evox Therapeutics Exosome Technologies Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Exosome Technologies Business of Evox Therapeutics (2019-2024)
    Table 55. Evox Therapeutics Recent Developments
    Table 56. Exosome Diagnostics, Inc. Basic Information List
    Table 57. Exosome Diagnostics, Inc. Description and Business Overview
    Table 58. Exosome Diagnostics, Inc. Exosome Technologies Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Exosome Technologies Business of Exosome Diagnostics, Inc. (2019-2024)
    Table 60. Exosome Diagnostics, Inc. Recent Developments
    Table 61. ExonanoRNA LLC., Basic Information List
    Table 62. ExonanoRNA LLC., Description and Business Overview
    Table 63. ExonanoRNA LLC., Exosome Technologies Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Exosome Technologies Business of ExonanoRNA LLC., (2019-2024)
    Table 65. ExonanoRNA LLC., Recent Developments
    Table 66. Codiak BioSciences Basic Information List
    Table 67. Codiak BioSciences Description and Business Overview
    Table 68. Codiak BioSciences Exosome Technologies Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Exosome Technologies Business of Codiak BioSciences (2019-2024)
    Table 70. Codiak BioSciences Recent Developments
    Table 71. Esperite Group Basic Information List
    Table 72. Esperite Group Description and Business Overview
    Table 73. Esperite Group Exosome Technologies Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Exosome Technologies Business of Esperite Group (2019-2024)
    Table 75. Esperite Group Recent Developments
    Table 76. Tavec Pharmaceuticals Basic Information List
    Table 77. Tavec Pharmaceuticals Description and Business Overview
    Table 78. Tavec Pharmaceuticals Exosome Technologies Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Exosome Technologies Business of Tavec Pharmaceuticals (2019-2024)
    Table 80. Tavec Pharmaceuticals Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Exosome Technologies Downstream Customers
    Table 84. Exosome Technologies Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Exosome Technologies Product Picture
    Figure 2. Global Exosome Technologies Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Exosome Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 4. Exosome Technologies Report Years Considered
    Figure 5. Global Exosome Technologies Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Exosome Technologies Revenue in 2023
    Figure 7. Exosome Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Transmission Electron Microscopy Picture
    Figure 9. Nanoparticle Tracking Analysis Picture
    Figure 10. Western Blot Molecular Marker Detection Picture
    Figure 11. Global Exosome Technologies Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Exosome Technologies Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Healthcare Providers
    Figure 14. Product Picture of Pharmaceutical & Biotechnology Companies
    Figure 15. Product Picture of Others
    Figure 16. Global Exosome Technologies Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Exosome Technologies Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Exosome Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Exosome Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Exosome Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Exosome Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Exosome Technologies Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Exosome Technologies Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Exosome Technologies Sales Value (%), (2019-2030)
    Figure 29. United States Exosome Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Exosome Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Exosome Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Exosome Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Exosome Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Exosome Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Exosome Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Exosome Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Exosome Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Exosome Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Exosome Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Exosome Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Exosome Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Exosome Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Exosome Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Exosome Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Exosome Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Exosome Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Exosome Technologies Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Exosome Technologies Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Exosome Technologies Sales Value by Application (%), 2023 VS 2030
    Figure 50. Exosome Technologies Industrial Chain
    Figure 51. Exosome Technologies Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.

The global market for Exosome Technologies was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Exosome Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Exosome Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Exosome Technologies was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Exosome Technologies include Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Evox Therapeutics, Exosome Diagnostics, Inc., ExonanoRNA LLC.,, Codiak BioSciences and Esperite Group, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Exosome Technologies, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Exosome Technologies by region & country, by Type, and by Application.

The Exosome Technologies market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Technologies.

Market Segmentation

Related Reports

Global Exosome Technologies Market Research Report 2024
Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.
Published: 2024-02-26
Pages: 80
USD 2900.00
(Single User License)
Global Exosome Technologies Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Exosome Technologies market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 128
USD 4900.00
(Single User License)
Global Exosome Technologies Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Exosome Technologies market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 76
USD 4250.00
(Single User License)

Global Exosome Technologies Market Research Report 2024
Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.
Published: 2024-02-26
Pages: 80
USD 2900.00 ()
Global Exosome Technologies Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Exosome Technologies market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 128
USD 4900.00 ()
Global Exosome Technologies Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Exosome Technologies market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 76
USD 4250.00 ()